Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 2.73 M2.82 M2.4 M3.78 M2.74 M3.32 M 12.24 M Research & development —————— — Operating income 12.14 M14.95 M5.49 M10.63 M10.19 M10.51 M 36.82 M Non-Operating Income, Total 5.69 M5.19 M-3 0006.96 M5.11 M9.77 M 21.84 M Interest expense, net of interest capitalized 8.09 M8.69 M7.85 M9.12 M7.29 M7.96 M 32.23 M Non-Operating Income, excl. Interest Expenses -2.4 M-3.5 M-7.86 M-2.16 M-2.18 M1.81 M -10.39 M Unusual income/expense —————— — Pretax income 5.43 M-1 M12.98 M482 K-1.17 M9.75 M 22.04 M Equity in earnings —————— — Taxes 26 K00002 000 2 000 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 3.54 M-2.45 M11.53 M-819 K-2.4 M8.64 M 16.95 M Discontinued operations —————— — Net income 3.54 M-2.45 M11.53 M-819 K-2.4 M8.64 M 16.95 M Dilution adjustment -8.51 M-967 K-1.02 M1.49 M-514 K227 K 183 K Preferred dividends 1.88 M1.63 M1.59 M1.54 M2.35 M1.72 M 7.2 M Diluted net income available to common stockholders -6.85 M-5.05 M8.91 M-866 K-5.27 M7.15 M 9.93 M Basic earnings per share (Basic EPS) -1.13 M-68.04 K26.45 K1.17 M-1 164409.96 1.2 M Diluted earnings per share (Diluted EPS) -1.13 M-68.04 K-1 195.21.2 M-1 1640.96 1.2 M Average basic shares outstanding 6.0774.14336.94445.434 524.8517.43 K — Diluted shares outstanding 184.6574.144 501.1825.49 K4 524.851.25 M — EBITDA 12.69 M15.54 M11.11 M12.48 M12.86 M10.71 M 47.16 M EBIT 6.45 M9.77 M5.5 M7.15 M7.63 M5.62 M 25.9 M Cost of revenue 432 K154 K270 K68 K313 K207 K 858 K Other cost of goods sold —————— — Depreciation & amortization (cash flow) 6.23 M5.78 M5.61 M5.32 M5.23 M5.09 M 21.26 M